Home -> Law Blog Directory -> Personal Injury Law Blogs -> A Georgia Lawyer

Personal Injury Law

: A Georgia Lawyer

Georgia/Florida News: Actos Diabetes Drug and Cardio Risks?

There have been several reports suggesting that the cardiovascular risks of the two drugs are allegedly about the same.

Both drugs are members of the family known as thizolidinediones, which decrease the insulin resistance of body tissues and modify the production of cholesterol. They are considered among the most powerful drugs for treating Type 2 diabetes but have been plagued by reports of side effects. A 2007 study of more than 200,000 Medicare patients suggested that Avandia, known generically as rosiglitazone, increased the risk of heart attack, cardiovascular disease, stroke and death by 30% to 40% compared with metformin and other, older diabetes drugs. That study also suggested that the increased risk was not observed with Actos, known generically as pioglitazone.

Source.

I am Hispanic, so I'm going to also start writing periodically in Spanish as well. Here's my first attempt:

Ha habido varios reportes que sugieren que los riesgos cardiovasculares de las dos drogas son supuestamente acerca de lo mismo.

Ambas drogas son miembros de la familia conocida como thizolidinediones, que disminuye la resistencia de insulina de tejidos de cuerpo y modifica la producción de colesterol. Son considerados entre las drogas más poderosas para de tipo tratar 2 diabetes pero han sido plagados por reportes de efectos secundario. Un 2007 estudio de más de 200.000 pacientes de Medicare sugirió que Avandia, conocido genéricamente como rosiglitazone, aumentó el riesgo de infarto, la enfermedad cardiovascular, el golpe y la muerte por 30% a 40% comparado con metformin y con otro, las drogas más viejas de la diabetes. Ese estudio también sugirió que el riesgo aumentado no fue observado con Actos, conocido genéricamente como pioglitazone.

Full post as published by A Georgia Lawyer on August 26, 2010 (boomark / email).